Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Marie Skłodowska-Curie Action · Running

DECODES Deciphering the Splicing Code in Human Disease

Coordinator
Universidad De Santiago De Compostela, Spain
Runs
1 January 2027 to 31 December 2030
Status
Running
EU funding
€4.6m
Total cost
—
Partners
16 organisations in 9 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101312753

What the project is doing

In the project's own words, from its summary on CORDIS.

Alternative splicing (AS) is a fundamental post-transcriptional mechanism that enables a single gene to generate multiple protein isoforms, dramatically expanding proteomic diversity. Dysregulation of AS is now recognised as a hallmark of human disease, contributing directly to cancer progression, neurodegeneration, metabolic syndromes, and numerous rare genetic disorders. Despite major technological advances, the translation of AS biology into clinical benefit remains limited by critical gaps in mechanistic understanding and by the absence of an integrated framework capable of driving discoveries from molecular insight to therapeutic intervention.

DECODES has been conceived to meet this challenge. It unites leading European scientists with highly complementary expertise to establish a coherent, interdisciplinary, and intersectoral research programme that bridges fundamental RNA biology with clinical and industrial translation. At its core, DECODES is a high-level doctoral program that will provide advanced, multidisciplinary training spanning computational genomics, structural biology, disease modelling, RNA biochemistry, medicinal chemistry and pharmacological screening.

Embedded in a fully international, interdisciplinary, and intersectoral (3I) environment, the program will equip 15 Doctoral Candidates with state-of-the-art research expertise, comprehensive transferable skills, and entrepreneurial competencies through structured coursework and immersive industrial secondments. By integrating these diverse disciplines into a unified pipeline for the discovery of pathogenic isoforms and the development of precision splicing-targeted therapies, DECODES will push the boundaries of RNA splicing research and train a new generation of scientists uniquely prepared to become future leaders in academia, biotechnology, and translational medicine.

Topics

Who is involved

OrganisationCityCountryRole
Universidad De Santiago De CompostelaSantiago De CompostelaSpainCoordinator
Eidgenoessische Technische Hochschule ZuerichZuerichSwitzerlandParticipant
Universitat BaselBaselSwitzerlandParticipant
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt GmbHNeuherbergGermanyParticipant
Technische Universitaet MuenchenMuenchenGermanyAssociatedpartner
Syddansk UniversitetOdense MDenmarkParticipant
Fundacio Centre De Regulacio GenomicaBarcelonaSpainParticipant
Fundacion KertorSantiago De CompostelaSpainAssociatedpartner
Universidad Pompeu FabraBarcelonaSpainParticipant
Academisch Ziekenhuis LeidenLeidenNetherlandsParticipant
Miedzynarodowy Instytut Mechanizmow I Maszyn Molekularnych Polskiej Akademii NaukWarszawaPolandParticipant
Faculdade De Medicina Da Universidade De LisboaLisboaPortugalAssociatedpartner
Fundacao Gimm - Gulbenkian Institute for Molecular MedicineLisboaPortugalParticipant
Astrazeneca ABSodertaeljeSwedenParticipant
Goeteborgs UniversitetGoeteborgSwedenAssociatedpartner
University of SouthamptonSouthamptonUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI